Nektar Therapeutics : SCHEDULE 14A - MarketScreener
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
Source: marketscreener.com
Stay updated with breaking news from Roya Whitfield. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
Nektar Therapeutics (NASDAQ:NKTR – Get Rating) Director Roy A. Whitfield sold 30,000 shares of Nektar Therapeutics stock in a transaction dated Wednesday, June 14th. The shares were sold at an average price of $0.57, for a total transaction of $17,100.00. Following the sale, the director now owns 216,250 shares in the company, valued at $123,262.50. […]